ConductScience.org, home

Paper10071354

Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events.

Jain AB and 4 others. Liver Transpl Surg, 1999. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events. Papers, record 10071354. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10071354

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events.
PubMed
Journal
Liver Transpl Surg
PubMed
Year
1999
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
1.35
iCite
Revised in PubMed
2025-05-29
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jain ABA B
2Kashyap RR
3Rakela JJ
4Starzl TET E
5Fung JJJ J

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunosuppressive AgentsMajor topic
Liver TransplantationMajor topic
TacrolimusMajor topic
Adult
Aged
Female
Follow-Up Studies
Graft Rejection
Humans
Incidence
Liver
Longitudinal Studies
Male
Middle Aged
Postoperative Complications
Reoperation
Survival Analysis

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 DK029961NIDDK NIH HHSUnited StatesR01DK029961PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04763096Evaluate the Efficacy and Safety of the ADVAGRAF®Results

Source ClinicalTrials.gov

Download CSV of trials

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121151749Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients.Clin Transplant1992https://conductscience.org/library/papers/21151749PubMed
21703354Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506.Transplant Proc1991https://conductscience.org/library/papers/1703354PubMed
38696542The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation.J Am Coll Surg1996https://conductscience.org/library/papers/8696542PubMed
49492860Higher incidence of diabetes in liver transplant recipients with hepatitis C.J Clin Gastroenterol1998https://conductscience.org/library/papers/9492860PubMed
59636567Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients.Transplant Proc1998https://conductscience.org/library/papers/9636567PubMed
67491685Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity.Transplantation1995https://conductscience.org/library/papers/7491685PubMed
71703340One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults.Transplant Proc1991https://conductscience.org/library/papers/1703340PubMed
87533358Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group.Transplant Proc1995https://conductscience.org/library/papers/7533358PubMed
97522431Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression.Ann Surg1994https://conductscience.org/library/papers/7522431PubMed
101689901Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.Transplant Proc1990https://conductscience.org/library/papers/1689901PubMed
116749635Evolution of liver transplantation.Hepatology1982https://conductscience.org/library/papers/6749635PubMed
121703682Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.Transplant Proc1991https://conductscience.org/library/papers/1703682PubMed
133279643Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report.Transplant Proc1988https://conductscience.org/library/papers/3279643PubMed
141721398Neurologic complications of FK 506.Transplant Proc1991https://conductscience.org/library/papers/1721398PubMed
151689886Early trials with FK 506 as primary treatment in liver transplantation.Transplant Proc1990https://conductscience.org/library/papers/1689886PubMed
162478846FK 506 for liver, kidney, and pancreas transplantation.Lancet1989https://conductscience.org/library/papers/2478846PubMed
171721347Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant.Transplant Proc1991https://conductscience.org/library/papers/1721347PubMed
188442153De novo malignancy following liver transplantation: a single-center study.Transplant Proc1993https://conductscience.org/library/papers/8442153PubMed
199825817Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data.Transplantation1998https://conductscience.org/library/papers/9825817PubMed
207520105Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group.Lancet1994https://conductscience.org/library/papers/7520105PubMed

See all 21 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
42908604Out of sight, out of mind, but at high risk: incidence, timing and risk factors for hyperkalemia after liver transplant discharge.Front Immunol2026https://conductscience.org/library/papers/42908604PubMed
35769149Efficacy and safety of prolonged-release versus immediate-release tacrolimus in de novo liver transplant recipients in South Korea: a randomized open-label phase 4 study (MAPLE).Korean J Transplant2019https://conductscience.org/library/papers/35769149PubMed
33802465A Time-Based Meta-Analysis on the Incidence of New Onset Diabetes after Liver Transplantation.J Clin Med2021https://conductscience.org/library/papers/33802465PubMed
29947691PREVALENCE AND RISK FACTORS OF HYPERKALEMIA AFTER LIVER TRANSPLANTATION.Arq Bras Cir Dig2018https://conductscience.org/library/papers/29947691PubMed
27512161Post-operative hypertension, a surrogate marker of the graft function and predictor of survival in living donor liver transplant recipients: A retrospective study.Indian J Anaesth2016https://conductscience.org/library/papers/27512161PubMed
26825098American Society of Nephrology Quiz and Questionnaire 2015: Electrolytes and Acid-Base Disorders.Clin J Am Soc Nephrol2016https://conductscience.org/library/papers/26825098PubMed
22555782An unusual complication of renal transplantation: a fistula between the sigmoid colon and the graft.Updates Surg2013https://conductscience.org/library/papers/22555782PubMed
12109922Single-agent immunosuppression after liver transplantation: what is possible?Drugs2002https://conductscience.org/library/papers/12109922PubMed
11005276The metabolic effects of cyclosporin and tacrolimus.J Endocrinol Invest2000https://conductscience.org/library/papers/11005276PubMed
10730553Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.Drugs2000https://conductscience.org/library/papers/10730553PubMed

Download CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
TACROLIMUSCHEMBL3989887Results1https://conductscience.org/library/drugs/CHEMBL3989887

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10071354

GET https://conductscience.org/api/papers/v1/10071354/references?page=2